L Cell

L Cell sells ingestible and topical longevity supplements built around cellular-repair ingredients such as NAD+ precursors, spermidine, fisetin and cyclo-astrogens. Single-item capsules start at ~$39, curated 3- to 6-month “Longevity Stacks” run $180-$350, placing the brand in the upper-mid price tier. All commerce is direct-to-consumer through lcell.life; no retail partners or marketplaces are used. The company positions itself as a “longevity systems” brand rather than a single-ingredient shop: every order is paired with free epigenetic-age testing (TruAge) and AI-driven dosage recalibration at 3-month intervals. Products are manufactured in FDA-registered California facilities, dual-tested for 98%+ purity, then shipped in cold-chain biodegradable packaging—details heavily featured in its marketing and investor decks. Core buyers are 30-55-year-old tech professionals, quantified-self enthusiasts and physicians who track biological-age clocks and want research-grade molecules without compounding themselves. The brand speaks in PubMed citations, offers GitHub-style changelogs for formula updates, and rewards users with NFT “longevity passports” that store their test data. L Cell competes in the premium anti-aging supplement space against generic NAD capsules and celebrity wellness pills; it differentiates by bundling diagnostic feedback loops, physician-formulated stacks and transparent Certificates of Analysis for every batch. By turning a commodity category into a data-driven subscription service, it commands 2-3× typical per-bottle pricing while maintaining sub-5% monthly churn.